- $151.73m
- $119.41m
- $118.71m
Brief: Assertio Holdings Inc Announces FDA Orange Book Listing For New Sympazan Oral Film Patent
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba
U.S. STOCKS ON THE MOVE-TFF Pharma, BioRestorative,
U.S. STOCKS ON THE MOVE-Energy firms, Nkarta, Domino's Pizza
Assertio up on raising full-year 2022 net product sales forecast
Brief: Assertio Increases Full-Year Net Product Sales Outlook To In Excess Of $152 Mln
Brief: Assertio Reports Third Quarter 2022 Financial Results
Brief: Assertio Holdings Signs Exclusive License For Sympazan Oral Film From Aquestive Therapeutics
U.S. STOCKS ON THE MOVE-Macy, Tritium, Ares Management
U.S. STOCKS ON THE MOVE-Energy firms, Natgas companies, ProPetro
U.S. STOCKS ON THE MOVE-Marin Software, JD.com, APA
Assertio slides on pricing $60 mln convertible debt deal
Brief: Assertio Prices $60 Mln Convertible Senior Notes Offering To Refinance Existing 13% Senior Secured Notes Due 2024
Brief: Assertio Announces Proposed Convertible Senior Notes Offering To Refinance Existing 13% Senior Secured Notes Due 2024
Assertio slides on convertible debt deal
U.S. STOCKS ON THE MOVE-Tiptree, Viatris, EV charging stocks
U.S. STOCKS ON THE MOVE-Elanco, Ceco, Monday.com
Assertio rises on Q2 profit beat, FY revenue forecast raise
Brief: Assertio reports Q2 results